Webcasted Industry Sessions

Kenes Multisite 2 Sites > ESPID 2024 > Webcasted Industry Sessions

Webcasted Industry Sessions

The sessions below were sponsored by GSK during the ESPID 2024 Meeting and are intended for HCPs only. 

They are not included in the main event CME/CPD credit.

PAEDIATRIC VACCINE EQUITY: INEQUALITY BETWEEN AND WITHIN EUROPEAN COUNTRIES – SUPPORTED BY GSK (MAY 20, 17:00-18:00)

The objective of this symposium is to introduce the concept of vaccine equity and the impact Healthcare Professionals can have in reducing health inequalities, outlining the current challenges for paediatric vaccination in Europe.

We will illustrate how recommendations, reimbursement and access to paediatric vaccines vary widely across European countries and regions within countries, and how these differences affect different stakeholders. In addition, we will discuss the importance of Healthcare Professionals in the vaccination journey and what they can do to help reduce vaccine inequity.

Paolo Bonanni
Full Professor of Hygiene in the Faculty of Medicine at the University of Florence, Italy, a position he has held since the year 2000.
Jose Antonio Navarro Alonso
Paediatrician and the founder and Honorary Member of the Spanish Association of Vaccinology.
Franziska Schaaf
Working in ambulatory pediatrics. Her special interest is still in infectiology and vaccinology.

Note that this recording is intended for HCPs only.

REWATCH SESSION
  • Paolo Bonanni – Welcome and introduction
  • Paolo Bonanni – Why do we need to care about vaccine equity in Europe?
  • Jose Antonio Navarro Alonso – A complex puzzle: Understanding European countries’ differences in terms of vaccine access and recommendations
  • Franziska Schaaf – Guiding parents and patients: the role of the HCP in reducing vaccine inequality
  • Paolo Bonanni – Roundtable discussion, Q&A Session
  • Paolo Bonanni – Conclusions

STRATEGIES FOR OPTIMIZING IMD PROTECTION AND DEFEATING MENINGITIS – SUPPORTED BY GSK (MAY 21, 13:15-14:15)

At GSK, the pursuit of defeating meningitis is one of our top priorities, and while we still have a journey ahead of us, YOU have been and continue to be integral to our success. So, for a moment, we’ll pause and reflect on the progress we’ve made in the last year by reviewing the post-pandemic data. Then, we’ll look to the future of meningococcal disease prevention by reviewing the WHO Roadmap to Defeat Meningitis by 2030.

As we reflect on our journey and the progress we’ve made together, one question still stands: ‘Are we on track to meet our goals?’. JOIN OUR EXPERTS PANEL to hear best practices and learnings from markets in varying places in their MenB (Meningococcal group B) vaccination implementation journey. GSK products will be discussed at the symposium.

For healthcare professionals only.

Federico Martinon-Torres
Pediatrician and clinical researcher, currently the coordinator and head of Pediatrics and Director of Translational Pediatrics and Infectious Diseases at the Hospital Clínico Universitario de Santiago (Spain), and Associate Professor in Pediatrics (University of Santiago).
Muhamed-Kheir Taha
Professor at Institut Pasteur in Paris France, head of the Unit Invasive Bacterial Infections, the French National Reference Centre for Meningococci and Haemophilus influenzae, and the WHO Collaborating Centre for meningitis. Current President of The European Meningococcal and Haemophilus Disease Society (EMGM)
Susanna Esposito
Full Professor of Pediatrics, Director of Specialty School of Pediatrics at the School of Medicine and Director of the Pediatric Clinic of the University of Parma. President of the World Association for Infectious Diseases and Immunological Disorders (WAidid)  and Chair of the Technical Committee in Infectious Diseases and Vaccination of the Italian Society of Pediatrics.

Note that this recording is intended for HCPs only.

REWATCH SESSION
  • Federico Martinon-Torres – Opening remarks & WHO Roadmap
  • Federico Martinon-Torres – Significant accomplishments in MenB protection and outlook for Europe and the globe
  • Muhamed-Kheir Taha – Driving factors for inclusion of MenB in the NIP in France, evolving local epidemiology post COVID19 and way forward (from infants to adolescents)
  • Susanna Esposito – Critical insights gleaned from local vaccination strategy and integration of booster policy for adolescents
  • All – Q&A Session